Different roles of alpha-noradrenergic receptor subtypes in regulating lordosis

Patricia A. Vincent, Janice E. Thornton, C Peterson, Harvey H. Feder
In: Pharmacology Biochemistry and Behavior · 1989 · vol. 34(1) , pp. 89–93 · doi:10.1016/0091-3057(89)90358-4 · PMID:2576314 · W2072448269
article OA: closed CC0
View on OpenAlex View on PubMed View at publisher

Abstract

Ovariectomized guinea pigs were given free estradiol (E) at hr 0 and 28, and progesterone (P) at hr 39. Experiment 1: The alpha-1 noradrenergic antagonist prazosin, but not the alpha-2 noradrenergic antagonist idazoxan, prevented display of lordosis behavior when administered systemically 30 min prior to E injections at either hr 0 or 28, or 30 min prior to both injections. Experiment 2: Multiple injections of idazoxan (i.e., 30 min prior to and 60 and 120 min after each E injection) failed to prevent display of lordosis. Experiment 3: E-primed animals were given a single injection of idazoxan 1 hr before P, or 5 hr after P. In those animals given idazoxan 1 hr before P, display of lordosis was not prevented. However, in animals given idazoxan once lordosis display had begun (i.e., 5 hr after P) ongoing lordosis behavior was blocked. These data suggest differential roles of alpha-noradrenergic receptor subtypes in regulation of lordosis: noradrenergic transmission through the alpha-1 subtype may mediate hormone-priming processes leading to lordosis, whereas transmission through the alpha-2 subtype may modulate ongoing lordosis responses.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

References (36)

SciLite annotations

organisms 3
guinea pigs multicellular animals multicellular animals
chemicals 7
estradiol progesterone prazosin idazoxan idazoxan idazoxan idazoxan

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
scilite
last seen: 2026-05-18T04:57:49.680383+00:00
License: CC0 · commercial use OK